[Acrysof(®) toric intraocular lens implantation in cataract surgery].
OBJECTIVE
To assess the medium term outcomes of Acrysof(®) toric intraocular lens implantation in 54 patients (54 eyes).


METHODS
Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), preoperative astigmatism, residual postoperative astigmatism, and global average and model-specific intraocular lens (IOL) rotation grade were analyzed.


RESULTS
At 2-months of follow-up,the mean UCVA was 0.83 (SD: 0.14) Snellen scale, with 73.9% of the patients ≥0.8, and 32.6% with 1.0. Mean BCVA achieved was 0.94 (SD: 0.10). Mean preoperatory astigmatism was -2.25 diopters (D) (SD: 0.78), and mean postoperative astigmatism was -0.32 D (SD: 0.56), with significant differences between both groups (p<0.001). Model-specific mean residual astigmatism was -0.1 D for T3, -0.27 D for T4 and -0.43 D for T5, without significant differences between the three models (p=0.483). Mean IOL-axis rotation grade was 3.87±3.25 degrees, with 91.6% of implanted lens within 10° of predicted axis.


CONCLUSIONS
T3, T4 and T5 Acrysof(®) Toric intraocular lenses can correct preoperative astigmatism with a high success rate in terms of UCVA, and residual postoperative astigmatism, with minimum IOL-rotation grade at 2 months follow-up period.
Departamento de Oftalmología, Clínica Universidad de Navarra, Pamplona, España. jzarranz@unav.es
J
J
Zarranz-Ventura
J
J
Moreno-Montañés
J
J
Caire Y González-Jáuregui
E
E
de Nova Fernández-Yáñez
L M
LM
Sádaba-Echarri
D000368:Aged; D000369:Aged, 80 and over; D001251:Astigmatism / Q000453:epidemiology / Q000517:prevention & control; D004867:Equipment Design; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular / Q000295:instrumentation; D007910:Lenses, Intraocular; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D012189:Retrospective Studies; D016896:Treatment Outcome; D014792:Visual Acuity